Advertisement

Programmed frozen embryo transfer cycle increased risk of hypertensive disorders of pregnancy: a multicenter cohort study in ovulatory women

Published:September 14, 2022DOI:https://doi.org/10.1016/j.ajogmf.2022.100752

      BACKGROUND

      Although live birth rates were comparable between programmed and natural frozen-thawed embryo transfer cycles, recent data showed that pregnancies after programmed cycle were associated with an increased risk of adverse perinatal outcomes, such as hypertensive disorders of pregnancy. Such a difference might be attributed to selection bias because patients with ovulation disorders are more likely to receive programmed endometrial preparation protocol than natural cycle.

      OBJECTIVE

      This study aimed to analyze whether programmed endometrial preparation protocol is associated with an increased risk of adverse perinatal outcomes compared with natural cycle during frozen embryo transfer in ovulatory women.

      STUDY DESIGN

      This regional multicenter retrospective cohort study was conducted in 5 reproductive medical centers in Southeast China. Patients with regular cycles (21–35 days), who underwent either programmed or natural cycle blastocyst frozen embryo transfer and delivered singleton live birth babies after 28 weeks of gestation between 2016 and 2019 were analyzed. Each patient only contributed 1 cycle per cohort. The patients’ frozen embryo transfer treatment cycles were linked to their obstetrical medication record, and a comprehensive medical record review was conducted to compare the maternal and neonatal outcomes between natural cycle and programmed cycle. Crude and adjusted odds ratios with 95% confidence intervals were calculated, and adjustment was made for relevant confounders.

      RESULTS

      Study samples included 499 natural cycle frozen embryo transfer cases and 900 programmed frozen embryo transfer cases. Pregnancies after programmed cycle were associated with increased odds of hypertensive disorders of pregnancy (adjusted odds ratio, 2.71; 95% confidence interval, 1.59–4.91) and preeclampsia (adjusted odds ratio, 2.71; 95% confidence interval, 1.17–6.23) compared with pregnancies after natural cycle. No significant difference was detected regarding other adverse perinatal outcomes between the 2 endometrial protocols. In subgroup analysis, both the subgroups of hormone replacement therapy and hormone replacement therapy with gonadotrophin-releasing hormone analogue pretreatment had increased odds of developing hypertensive disorders of pregnancy than the natural cycle group. The risk of developing preeclampsia was higher in the hormone replacement therapy with gonadotrophin-releasing hormone analogue pretreatment subgroup than in the other 2 groups (adjusted odds ratio, 4.99; 95% confidence interval, 1.94–12.82) (aOR, 2.47; 95% CI, 1.17–5.18).

      CONCLUSION

      Pregnancies after programmed frozen embryo transfer were associated with higher risks of hypertensive disorders of pregnancy in ovulatory women. The hormone replacement therapy with gonadotrophin-releasing hormone analogue pretreatment cycle led to the highest risk of preeclampsia among the 3 protocols.

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology MFM
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • De Geyter C
        • Calhaz-Jorge C
        • Kupka MS
        • et al.
        ART in Europe, 2014: results generated from European registries by ESHRE: the European IVF-Monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE).
        Hum Reprod. 2018; 33: 1586-1601
        • Roque M
        • Haahr T
        • Geber S
        • Esteves SC
        • Humaidan P.
        Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes.
        Hum Reprod Update. 2019; 25: 2-14
        • Maheshwari A
        • Pandey S
        • Amalraj Raja E
        • Shetty A
        • Hamilton M
        • Bhattacharya S
        Is frozen embryo transfer better for mothers and babies? Can cumulative meta-analysis provide a definitive answer?.
        Hum Reprod Update. 2018; 24: 35-58
        • Sha T
        • Yin X
        • Cheng W
        • Massey IY.
        Pregnancy-related complications and perinatal outcomes resulting from transfer of cryopreserved versus fresh embryos in vitro fertilization: a meta-analysis.
        Fertil Steril. 2018; 109 (e9): 330-342
        • Mackens S
        • Santos-Ribeiro S
        • van de Vijver A
        • et al.
        Frozen embryo transfer: a review on the optimal endometrial preparation and timing.
        Hum Reprod. 2017; 32: 2234-2242
        • Ghobara T
        • Gelbaya TA
        • Ayeleke RO.
        Cycle regimens for frozen-thawed embryo transfer.
        Cochrane Database Syst Rev. 2017; 7CD003414
        • von Versen-Höynck F
        • Schaub AM
        • Chi YY
        • et al.
        Increased preeclampsia risk and reduced aortic compliance with in vitro fertilization cycles in the absence of a corpus luteum.
        Hypertension. 2019; 73: 640-649
        • Ginström Ernstad E
        • Wennerholm UB
        • Khatibi A
        • Petzold M
        • Bergh C
        Neonatal and maternal outcome after frozen embryo transfer: increased risks in programmed cycles.
        Am J Obstet Gynecol. 2019; 221 (e1–18): 126
        • Zong L
        • Liu P
        • Zhou L
        • Wei D
        • Ding L
        • Qin Y.
        Increased risk of maternal and neonatal complications in hormone replacement therapy cycles in frozen embryo transfer.
        Reprod Biol Endocrinol. 2020; 18: 36
        • Bartsch E
        • Medcalf KE
        • Park AL
        • Ray JG
        • High Risk of Pre-eclampsia Identification Group
        Clinical risk factors for pre-eclampsia determined in early pregnancy: systematic review and meta-analysis of large cohort studies.
        BMJ. 2016; 353: i1753
        • Saito K
        • Kuwahara A
        • Ishikawa T
        • et al.
        Endometrial preparation methods for frozen-thawed embryo transfer are associated with altered risks of hypertensive disorders of pregnancy, placenta accreta, and gestational diabetes mellitus.
        Hum Reprod. 2019; 34: 1567-1575
        • Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group
        Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).
        Hum Reprod. 2004; 19: 41-47
      1. American Diabetes Association. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2020.
        Diabetes Care. 2020; 43: S14-S31
        • Weinert LS.
        International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups Consensus Panel.
        Diabetes Care. 2010; 33: e97
        • Zhu L
        • Zhang R
        • Zhang S
        • et al.
        [Chinese neonatal birth weight curve for different gestational age].
        Zhonghua Er Ke Za Zhi. 2015; 53: 97-103
        • Brown MA
        • Magee LA
        • Kenny LC
        • et al.
        The hypertensive disorders of pregnancy: ISSHP classification, diagnosis & management recommendations for international practice.
        Pregnancy Hypertens. 2018; 13: 291-310
        • von Versen-Höynck F
        • Conrad KP
        • Baker VL.
        Which protocol for frozen-thawed embryo transfer is associated with the best outcomes for the mother and baby?.
        Fertil Steril. 2021; 115: 886-887
        • Jing S
        • Li XF
        • Zhang S
        • Gong F
        • Lu G
        • Lin G.
        Increased pregnancy complications following frozen-thawed embryo transfer during an artificial cycle.
        J Assist Reprod Genet. 2019; 36: 925-933
        • Wang Z
        • Liu H
        • Song H
        • et al.
        Increased risk of pre-eclampsia after frozen-thawed embryo transfer in programming cycles.
        Front Med (Lausanne). 2020; 7: 104
        • Palomba S
        • de Wilde MA
        • Falbo A
        • Koster MP
        • La Sala GB
        • Fauser BC
        Pregnancy complications in women with polycystic ovary syndrome.
        Hum Reprod Update. 2015; 21: 575-592
        • Sun M
        • Maliqueo M
        • Benrick A
        • et al.
        Maternal androgen excess reduces placental and fetal weights, increases placental steroidogenesis, and leads to long-term health effects in their female offspring.
        Am J Physiol Endocrinol Metab. 2012; 303: E1373-E1385
        • Asserhøj LL
        • Spangmose AL
        • Aaris Henningsen AK
        • et al.
        Adverse obstetric and perinatal outcomes in 1,136 singleton pregnancies conceived after programmed frozen embryo transfer (FET) compared with natural cycle FET.
        Fertil Steril. 2021; 115: 947-956
        • Fishel Bartal M
        • Lindheimer MD
        • Sibai BM
        Proteinuria during pregnancy: definition, pathophysiology, methodology, and clinical significance.
        Am J Obstet Gynecol. 2022; 226: S819-S834
        • Zhou R
        • Zhang X
        • Huang L
        • et al.
        The impact of different cycle regimens on birthweight of singletons in frozen-thawed embryo transfer cycles of ovulatory women.
        Fertil Steril. 2022; 117: 573-582
        • Conrad KP
        • Graham GM
        • Chi YY
        • et al.
        Potential influence of the corpus luteum on circulating reproductive and volume regulatory hormones, angiogenic and immunoregulatory factors in pregnant women.
        Am J Physiol Endocrinol Metab. 2019; 317: E677-E685
        • von Versen-Höynck F
        • Narasimhan P
        • Selamet Tierney ES
        • et al.
        Absent or excessive corpus luteum number is associated with altered maternal vascular health in early pregnancy.
        Hypertension. 2019; 73: 680-690
        • Ogueh O
        • Brookes C
        • Johnson MR.
        A longitudinal study of the maternal cardiovascular adaptation to spontaneous and assisted conception pregnancies.
        Hypertens Pregnancy. 2009; 28: 273-289
        • Dröge LA
        • Perschel FH
        • Stütz N
        • et al.
        Prediction of preeclampsia-related adverse outcomes With the sFlt-1 (soluble fms-like tyrosine kinase 1)/PlGF (placental growth factor)-ratio in the clinical routine: a real-world study.
        Hypertension. 2021; 77: 461-471
        • Lee MS
        • Cantonwine D
        • Little SE
        • et al.
        Angiogenic markers in pregnancies conceived through in vitro fertilization.
        Am J Obstet Gynecol. 2015; 213 (e1–8): 212
      2. Gestational hypertension and preeclampsia: ACOG Practice Bulletin Summary, Number 222.
        Obstet Gynecol. 2020; 135: 1492-1495
        • Rauschemberger MB
        • Sandoval MJ
        • Massheimer VL.
        Cellular and molecular actions displayed by estrone on vascular endothelium.
        Mol Cell Endocrinol. 2011; 339: 136-143
        • Shynlova O
        • Tsui P
        • Jaffer S
        • Lye SJ.
        Integration of endocrine and mechanical signals in the regulation of myometrial functions during pregnancy and labour.
        Eur J Obstet Gynecol Reprod Biol. 2009; 144: S2-10
        • Berkane N
        • Liere P
        • Oudinet JP
        • et al.
        From pregnancy to preeclampsia: a key role for estrogens.
        Endocr Rev. 2017; 38: 123-144
        • Farland LV
        • Prescott J
        • Sasamoto N
        • et al.
        Endometriosis and risk of adverse pregnancy outcomes.
        Obstet Gynecol. 2019; 134: 527-536
        • Garrido-Gómez T
        • Castillo-Marco N
        • Cordero T
        • Simón C.
        Decidualization resistance in the origin of preeclampsia.
        Am J Obstet Gynecol. 2022; 226: S886-S894
        • Fukui A
        • Funamizu A
        • Yokota M
        • et al.
        Uterine and circulating natural killer cells and their roles in women with recurrent pregnancy loss, implantation failure and preeclampsia.
        J Reprod Immunol. 2011; 90: 105-110